ZyVersa Therapeutics, Inc.
ZVSA· OTC
ZVSAZyVersa Therapeutics, Inc.
Filed Mar 27, 2025 · 10-K · 86 days after period end · 0001641172-25-000862
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|
| Net Income | -$1.42M | -$13.34M | -$12.25M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ZyVersa Therapeutics, Inc. · CIK 1859007 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 27, 2025 · 86 d after period end
